Bedrosian Camille L bought AMLX
March 5, 2026 · Form 4 insider transaction
Bedrosian Camille L bought 95,990 shares of Amylyx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
95,990
Price
$0.00
Total value
N/A
InsiderBedrosian Camille L
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after265,285
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date.